SKI Market

Indian Indices

Sensex

84,961.14 -102.20
( -0.12%)

Global Indices

Nasdaq

49,481.66 483.47
(0.99%)

Dow Jones

6,965.42 42.37
(0.61%)

Hang Seng

51,924.52 -593.56
(-1.13%)

Nikkei 225

10,039.39 -83.34
(-0.82%)

Forex

USD-INR

90.21 0.17
(0.19%)

EUR-INR

105.52 0.01
(0.01%)

GBP-INR

121.54 0.38
(0.31%)

JPY-INR

0.58 0.00
(0.26%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Neuland Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524558

INE794A01010

1255.9414887

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NEULANDLAB

95.32

18582.17

EPS(TTM)

Face Value()

Div & Yield %

151.95

0.08

Back

KCL Infra Projects reports standalone net loss of Rs 0.33 crore in the September 2025 quarter

Nov 16,2025

Net loss of KCL Infra Projects reported to Rs 0.33 crore in the quarter ended September 2025 as against net profit of Rs 0.07 crore during the previous quarter ended September 2024. Sales reported to Rs 1.02 crore in the quarter ended September 2025. There were no Sales reported during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1.02	0	0
OPM %	-64.71	0	-
PBDT	-0.44	0.11	PL
PBT	-0.45	0.09	PL
NP	-0.33	0.07	PL

84,961.14 -102.20 ( -0.12%)

49,481.66 483.47 (0.99%)

6,965.42 42.37 (0.61%)

51,924.52 -593.56 (-1.13%)

10,039.39 -83.34 (-0.82%)

90.21 0.17 (0.19%)

105.52 0.01 (0.01%)

121.54 0.38 (0.31%)

0.58 0.00 (0.26%)